Levent Canyurt, CEO and founder of BIEM Ilac, shares how he transformed the company from a domestic pharmaceutical distributor into an international player, with an innovative portfolio for the treatment of rare diseases. He also highlights the importance of greater collaboration between stakeholders in the Turkish biotech industry and gives insights on his vision for BIEM both in the domestic and international market.
There is no doubt that there is a crisis in Turkey currently, but BIEM is trying to see this as a chance to become a global company in the healthcare industry within three years
